Responses
Pharmacotherapies for COPD
P272 Improvements in exacerbation rates with single inhaler triple therapy versus dual ics/laba therapy in patients with advanced chronic obstructive pulmonary disease (copd): subgroup analyses of the phase iii fulfil study
Compose a Response to This Article
Other responses
No responses have been published for this article.